Medline Statistics
Total Valuation
Medline has a market cap or net worth of $59.66 billion. The enterprise value is $75.31 billion.
Important Dates
The next confirmed earnings date is Wednesday, February 25, 2026, before market open.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Medline has 1.35 billion shares outstanding. The number of shares has decreased by -0.11% in one year.
| Current Share Class | 832.20M |
| Shares Outstanding | 1.35B |
| Shares Change (YoY) | -0.11% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | 0.72% |
| Owned by Institutions (%) | 4.84% |
| Float | 320.24M |
Valuation Ratios
The trailing PE ratio is 47.12 and the forward PE ratio is 36.02. Medline's PEG ratio is 5.42.
| PE Ratio | 47.12 |
| Forward PE | 36.02 |
| PS Ratio | 28.24 |
| Forward PS | 4.00 |
| PB Ratio | 46.19 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 59.13 |
| P/OCF Ratio | 41.37 |
| PEG Ratio | 5.42 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 23.15, with an EV/FCF ratio of 74.64.
| EV / Earnings | 59.49 |
| EV / Sales | 2.75 |
| EV / EBITDA | 23.15 |
| EV / EBIT | 33.47 |
| EV / FCF | 74.64 |
Financial Position
The company has a current ratio of 3.66, with a Debt / Equity ratio of 0.99.
| Current Ratio | 3.66 |
| Quick Ratio | 1.69 |
| Debt / Equity | 0.99 |
| Debt / EBITDA | 4.95 |
| Debt / FCF | 16.50 |
| Interest Coverage | 2.21 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 6.51% |
| Return on Capital Employed (ROCE) | 6.57% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $637,884 |
| Profits Per Employee | $29,442 |
| Employee Count | 43,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Medline has paid $81.00 million in taxes.
| Income Tax | 81.00M |
| Effective Tax Rate | 6.01% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 55.62 |
| Average Volume (20 Days) | 3,988,945 |
Short Selling Information
The latest short interest is 12.89 million, so 0.96% of the outstanding shares have been sold short.
| Short Interest | 12.89M |
| Short Previous Month | n/a |
| Short % of Shares Out | 0.96% |
| Short % of Float | 4.02% |
| Short Ratio (days to cover) | 0.69 |
Income Statement
In the last 12 months, Medline had revenue of $27.43 billion and earned $1.27 billion in profits. Earnings per share was $0.07.
| Revenue | 27.43B |
| Gross Profit | 7.46B |
| Operating Income | 2.25B |
| Pretax Income | 1.35B |
| Net Income | 1.27B |
| EBITDA | 3.25B |
| EBIT | 2.25B |
| Earnings Per Share (EPS) | $0.07 |
Full Income StatementBalance Sheet
The company has $997.00 million in cash and $16.65 billion in debt, with a net cash position of -$15.65 billion or -$11.63 per share.
| Cash & Cash Equivalents | 997.00M |
| Total Debt | 16.65B |
| Net Cash | -15.65B |
| Net Cash Per Share | -$11.63 |
| Equity (Book Value) | 16.77B |
| Book Value Per Share | 0.96 |
| Working Capital | 6.95B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.44 billion and capital expenditures -$433.00 million, giving a free cash flow of $1.01 billion.
| Operating Cash Flow | 1.44B |
| Capital Expenditures | -433.00M |
| Free Cash Flow | 1.01B |
| FCF Per Share | $0.75 |
Full Cash Flow StatementMargins
Gross margin is 27.18%, with operating and profit margins of 8.20% and 4.62%.
| Gross Margin | 27.18% |
| Operating Margin | 8.20% |
| Pretax Margin | 4.91% |
| Profit Margin | 4.62% |
| EBITDA Margin | 11.86% |
| EBIT Margin | 8.20% |
| FCF Margin | 3.68% |
Dividends & Yields
Medline does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.11% |
| Shareholder Yield | 0.11% |
| Earnings Yield | 2.12% |
| FCF Yield | 1.69% |
Analyst Forecast
The average price target for Medline is $47.41, which is 6.97% higher than the current price. The consensus rating is "Buy".
| Price Target | $47.41 |
| Price Target Difference | 6.97% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |
